The human endometrium undergoes regular cyclical changes under the endocrine control of oestrogens and progesterone acting via specific nuclear receptors. 
Introduction
During the menstrual cycle, the endometrium undergoes regu¬ lar cyclical changes so as to offer a suitable environment for the implantation of the fertilized ovum. These changes are under the influence of oestrogen and progesterone. Oestrogens induce endometrial proliferation during the preovulatory phase of the menstrual cycle (Ferenczy et al, 1979) , whereas proges¬ terone induces secretory changes in the oestrogen-primed proliferative endometrium during the post-ovulatory phase (Katzenellenbogen, 1980) . The actions of progesterone and oestradiol are mediated by specific intracellular receptor pro¬ teins located in stromal and epithelial endometrial cells (Healy and Hodgen, 1983) . Concentrations of progesterone receptors have been shown to be increased by oestrogen (Kreitmann et al, 1979) and growth factors (Sumida et al, 1988) , and decreased by progesterone and progesterone analogues (Katzenellenbogen, 1980) .
Regulation of the synthesis of progesterone receptors in breast cancer cells occurs at transcription (Read et al, 1988) . In the endometrium, the concentration of progesterone receptors has been shown to vary throughout the menstrual cycle, although the mechanism by which this is achieved has not been established (Bayard et al, 1978) . In the present investigation the relationship between mRNA encoding endometrial proges¬ terone receptors and the progesterone receptor protein was studied throughout the menstrual cycle.
Materials and Methods

Tissue samples
Endometrial samples were collected from 44 women, age 36.8 ± 6.2 years (mean ± sd) with normal regular menstrual cycles undergoing routine gynaecology surgery. Women who had received hormonal treatment in the preceding six months were excluded from the study. Ethical (Noyes et al, 1950) and the serum profiles of progesterone and oestradiol (Yussman et al, 1970) . The menstrual cycle was divided into four phases and the samples were allocated according to the phase of the cycle: early proliferative (EP) days 6-9 (n = 10); late proliferative (LP) days [10] [11] [12] [13] [14] (Bradford, 1976 (Misrahi et al, 1987 ) and ß-actin cDNA (Ponte et al, 1984) amplification were derived from the published cDNA sequences. ß-Actin was used as an invariant control sequence in the PCR reactions to correct for reaction-toreaction variation in amplification efficiency. The primer se¬ quences, the codons amplified and the expected sizes of the PCR product generated from the progesterone receptor cDNA are listed in Table 1 Quantification of mRNA encoding for the progesterone receptor by RT-PCR Initially, several primer sets were used to amplify progester¬ one receptor cDNA and, in each case, a product of the expected size was generated (Fig. 2) . Primer set 3 was used in Fig. 2 subsequent analyses since the product was easily separated from the ß-actin product and the set worked well under the multiplex PCR conditions. The intron-exon structure is not known but on the basis of the intron-exon structure of the chicken progesterone receptor, this primer set was expected to cross an intron (Huckaby et al, 1987) . This was confirmed for the human progesterone receptor gene, as a 195 bp product was generated using primer set three with the cDNA, but not with genomic DNA. However, a product of 2-3 kb was generated using genomic DNA suggesting that introns in the human gene are of a similar size to the chicken (Fig. 3) . As products of 195 bp were generated only with the first strand cDNA and not with the genomic DNA, the possibility that the products generated from the endometrial cDNA were derived Fig. 4 (Fig. 4) . mRNA encoding for the progesterone receptor and ß-actin was successfully detected in all endometrial samples by RT-PCR, examples of which are shown (Fig. 5) . No significant differences were found between the different stages of the menstrual cycle (Fig. 6) . In cases in which sufficient RNA was available, conventional northern blots were performed using the progesterone receptor cDNA probe and ß-actin cDNA probes as independent means of verifying the RT-PCR results. In each case, the results of northern blotting were consistent with those obtained by RT-PCR. 
Discussion
The changes in the concentration of endometrial progesterone receptor protein observed throughout the menstrual cycle in the study reported here are in agreement with previous observations (Bayard et al, 1978; Levy et al, 1980; Bergqvist and Ferno, 1993 cycle. This method has the advantage of being independent of steroid-binding activity and also recognizes the 120 kDa and 95 kDa molecular mass forms of the human progesterone receptor. In agreement with previous studies using this method, the concentration of progesterone receptors was found to increase during the proliferative phase and reach a maximum in the late proliferative phase, and then to fall to low concentrations by the late secretory phase (Bergqvist and Ferno, 1993) . Similar results were also observed in studies using steroid-binding methods that measure the endometrial cytosolic, nuclear and total progesterone concentrations (Bayard et al, 1978; Levy et al, 1980) . In addition, immuno¬ cytochemical analysis of the progesterone receptor using monoclonal antibodies have shown similar variations through¬ out the menstrual cycle (Garcia el al, 1988 (Rosser et al, 1993) . Detailed analysis of the different actin isoforms in immature rat uteri revealed only a 1.4-fold increase in ß-actin (Hsu and Frankel, 1987 (Brandon et al, 1993 (Brandon et al, 1993 (Read et al, 1988 (Misrahi et al, 1987 (Jeltsch et al, 1986 
